Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of miconazole nitrate + domiphen bromide vaginal cream for acute vulvovaginal candidiasis
2021-001201-75Phase 2Completed
- Sponsor
- Purna Female Healthcare
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of miconazole and domiphen in vulvovaginal candidiasis (VVC) (3 arms), sponsored by Purna Female Healthcare. Primary endpoints: Cure rate of vulvovaginal candidiasis at Day 15 and Optimal domiphen bromide dose selection through Week 12. Started Jul 2021; status: completed.
02
Drugs
miconazoledomiphen
03
Conditions
vulvovaginal candidiasis (VVC)
Beyond the preview
Go deeper on 2021-001201-75.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-001201-75.